Working with the Senate HELP Committee
Johnson & Johnson has accepted the Senate HELP Committee’s invitation for our Chairman and CEO to participate in a hearing and look forward to building an understanding of our longstanding efforts to improve affordability and access to medicines.
2022 U.S. Transparency Report
Our net prices declined for the sixth year in a row in 2022. Unfortunately, the reality for millions of patients is growing affordability and health equity gaps caused by underinsurance and inadequate insurance benefit design driven by middlemen, including pharmacy benefit managers.
